NOUV News and Press, Nouveau Life Pharms Inc From 05/10/19

DALLAS, May 10, 2019 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) and Nouveau, Inc. (Nouveau Life Pharmaceuticals dba Nouveau) (USOTC: NOUV) (“NOUV”) today confirmed plans to issue a dividend of NOUV stock to PURA shareholders i...

DALLAS, May 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced CEO Frederick Ferri is leading a site survey today of the cannabis extraction lab KALY is building in partnership with No...

DALLAS, April 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Alternet Systems, Inc. (USOTC: ALYI) (“ALYI”) recently posted its 2018 financial statement reporting its first quarter million in revenue generated since the company shifted its business direction toward energy stor...

DALLAS, April 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Alternet Systems, Inc. (USOTC: ALYI) (“ALYI”) today published a presentation to provide details on the company’s plan to create over $50 million in value from its African strategy.  The company announced...

DALLAS, April 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published a presentation elaborating on the company’s overall strategy to discover, develop and commercialize novel therap...

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a treatment for epilepsy derived from the company’s patented cannabis extraction method is under research and de...

DALLAS, April 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed plans to reveal a fourth research and development initiative for a treatment of a heath issue with a cannabis extract d...

DALLAS, April 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its ongoing research and development of a cannabis pain management treatment derived from the company’s patented...

DALLAS, April 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today unveiled its ongoing research and development of a cannabis treatment for Type 2 Diabetes.  Kali-Extracts, through its paten...

DALLAS, March 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion.  KALY’s patented extrac...